Open tender · Ukraine · Public tender
Лоперамід таблетки/капсули по 2 мг (Loperamide) за кодом ДК 021:2015:33600000-6-Фармацевтична продукція
In EnglishLoperamide tablets/capsules 2 mg (Loperamide) under DK 021:2015 code: 33600000-6 - Pharmaceutical products
ВІЙСЬКОВА ЧАСТИНА А4615 in Ukraine is inviting bids for “Loperamide tablets/capsules 2 mg (Loperamide) under DK 021:2015 code: 33600000-6 - Pharmaceutical products”. Bids close on 14 October 2026, 09:00 EEST; the estimated value is UAH 34,200. Who can bid: Bidder, owners or shareholders must not be under sanctions banning public procurement; Bidder must not be a legal entity with 10% or more owned by Russia, Belarus or Iran. askTender lists every requirement to qualify and checks whether your company meets them.
The tender in brief
Supply of 30,000 loperamide 2 mg tablets or capsules to Dnipro, for medicine suppliers
A military unit in Dnipro is buying 30,000 units of loperamide 2 mg tablets or capsules (ATC A07DA03). The expected value is 34,200 UAH. The contract is awarded by price quotation. Goods must not originate from Russia, Belarus or Iran.
Who can win it
- Bidder, owners or shareholders must not be under sanctions banning public procurement
- Bidder must not be a legal entity with 10% or more owned by Russia, Belarus or Iran
- Goods must not originate from Russia, Belarus or Iran
Key facts
- Estimated value
- UAH 34,200
Before you bid, askTender
Everything else is in your askTender account
The requirements to qualify, the eligibility check and the bid documents for this tender are in your askTender account.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: Prozorro. · Sources & licences